Global Access to Vaccines

Excerpted from The Domini 2021 Impact Report

Valuing human dignity requires helping people to plan for, and thrive into the future. This is why we believe preventative health care is part of our goal of advancing human dignity. In 2021, we were invested in two companies at forefront of providing preventative care: Pfizer and Moderna.

In 2020, Pfizer partnered with BioNTech to develop the first Covid-19 vaccine approved for emergency use by the U.S. Food and Drug Administration. Moderna had been working with mRNA technology for more than a decade, researching and developing treatments for rare diseases and vaccines for underserved populations. Through their partnership with U.S. agencies, Moderna was able to gain approval of its first product. These were the first two mRNA vaccines to receive regulatory approval anywhere, an outstanding achievement in medical innovation.

Although both companies were meeting our goals for healthcare – producing innovative, preventative, products – we recognized that there were likely to be chal-lenges to universal access to mRNA vaccines. Therefore, we joined other investors to engage Pfizer and Moderna to influence them to develop and pursue reasonable solutions to promote global access to their vaccines.

We focused on a known solution to problems of health access technology transfer: teaching others the methods of producing the vaccines while decentralizing global production. By the time we spoke to Pfizer, it had already taken steps to expand global manufacturing capacity, specifically adding to capacity in Brazil and South Africa. However, dialogue with Moderna revealed a hesitancy to share its vaccine know-how, and only vague promises about global production.

Finding ourselves at an impasse with Moderna, we joined Oxfam in requesting from the company a feasibility report to assess the opportunities, benefits, and risks of global manufacturing and technology transfer. We filed a proposal on the company’s annual proxy statement to allow other shareholders of the company to weigh in on this important matter related to global health access.

At Domini we invest in companies that we believe on balance are addressing their key sustainability challenges. We also use our voice as investors to work to improve corporate behavior and create alignment with our goals of promoting ecological sustainability and human dignity.

You can watch our webinar, Health Justice: Attaining Global & Equitable Access to COVID-19 Vaccines, at https://www.domini.com/insights/global_vaccine_webinar


Before investing, consider each Fund’s investment objectives, risks, charges and expenses. Contact us at 1.800.582.6757 for a prospectus containing this and other important information. Read it carefully.

The Domini Funds are not bank deposits and are not insured. Investing involves risk, including possible loss of principal. The market value of Fund investments will fluctuate. The Domini Impact Equity Fund is subject to certain risks including impact investing, portfolio management, information, market, recent events, and mid- to large-cap companies risks. The Domini International Opportunities Fund is subject to certain risks including foreign investing, geographic focus, country, currency, impact investing, and portfolio management risks. The Domini Sustainable Solutions Fund is subject to certain risks including sustainable investing, portfolio management, information, market, recent events, mid- to large-cap companies and small-cap companies risks. The Domini Impact International Equity Fund is subject to certain risks including foreign investing, emerging markets, geographic focus, country, currency, impact investing, and portfolio management risks. Investing internationally involves special risks, such as currency fluctuations, social and economic instability, differing securities regulations and accounting standards, limited public information, possible changes in taxation, and periods of illiquidity. These risks may be heightened in connection with investments in emerging market countries. The Domini Impact Bond Fund is subject to certain risks including impact investing, portfolio management, style, information, market, recent events, interest rate and credit risks.

The Adviser’s evaluation of environmental and social factors in its investment selections and the timing of the Subadviser’s implementation of the Adviser’s investment selections will affect the Fund’s exposure to certain issuers, industries, sectors, regions, and countries and may impact the relative financial performance of the Fund depending on whether such investments are in or out of favor. The value of your investment may decrease if the Adviser’s or Subadviser’s judgement about Fund investments does not produce the desired results. There is a risk that information used by the Adviser to evaluate environmental and social factors, may not be readily available or complete, which could negatively impact the Adviser’s ability to evaluate such factors and Fund performance.Unless otherwise stated the information in this report is for the 2021 calendar year.

This Impact Report is provided for informational purposes only. Nothing herein is to be considered a recommendation concerning the merits of any noted company, or an offer of sale or a solicitation of an offer to buy shares of any Fund or company referenced herein. Such offering is only made by prospectus, which includes details as to the offering price and other material information. Please read the prospectus carefully before investing.

All studies referenced herein were conducted by independent third parties. They have not been independently verified by Domini and are provided for informational purposes only. The inclusion of these studies herein does not constitute financial advice. We do not attest to the methodologies used.

The Domini Funds are only offered for sale in the United States. The Domini Funds are distributed by DSIL Investment Services LLC (DSILD), Member FINRA. Domini Impact Investments LLC (Domini) is the Funds’ Adviser. Domini Im-pact International Equity Fund and Domini Impact Bond Fund are subadvised by Wellington Management Company LLP. DSILD and Domini are not affiliated with Wellington Management Company LLP. Domini Impact Equity Fund, Domini International Opportunities Fund and Domini Sustainable Solutions Fund are subadvised by SSGA Funds Management, Inc. DSILD and Domini are not affiliated with SSGA Funds Management, Inc.

Domini Impact Investments®, Domini®, Investing for Good®, and The Way You Invest Matters® are registered service marks of Domini Impact Investments LLC (“Domini”). Domini International Opportunities Fund℠, Domini Sustainable Solutions Fund℠, Domini Impact Equity Fund℠, Way You Invest Matters® are registered service marks of Domini Impact Investments LLC (“Domini”). Domini International Opportunities Fund℠, Domini Sustainable Solutions Fund℠, Domini Impact Equity Fund℠, Domini Impact International Equity Fund℠, Domini Impact Bond FundSM℠ are service marks of Domini. The Domini Impact Investment Standards is copyright © 2006-2022 by Domini Impact Investments LLC. All rights reserved. 2/22


Check the background of DSIL Investment Services LLC and its investment professionals on FINRA's BrokerCheck. Before investing, consider the Domini Funds’ investment objectives, risks, charges, and expenses. View or order a prospectus. Read it carefully.

DSIL Investment Services LLC (DSILD) distributor, Member FINRA.

Domini Impact Investments LLC (Domini) is the Funds’ investment manager. The Funds are subadvised by unaffiliated entities.

Eye iconEye slash icon